The latest approval adds another generic option to the market, but it's not expected to change access in states where abortion is still restricted or banned. HealthDay News — A new low-cost version of ...
The US Food and Drug Administration (FDA) has approved a supplemental Abbreviated New Drug Application (sNDA) sponsored by Par Pharmaceuticals for a 300 mg, extended-release version of the popular ...
The Food and Drug Administration (FDA) on Wednesday granted accelerated approval to Bayer AG‘s (OTC: BAYRY) Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. The approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results